Meaxon Injection contains Methylcobalamin 500 mcg, a biologically active form of vitamin B12 essential for neurological function and hematopoiesis. This injectable formulation is indicated for the treatment of vitamin B12 deficiency, which may result from pernicious anemia, malabsorption syndromes, or dietary insufficiency. Methylcobalamin plays a critical role in the synthesis of myelin and the maintenance of nerve cells, making Meaxon Injection particularly beneficial in neuropathies, including diabetic neuropathy and peripheral neuropathy. The administration of Meaxon Injection facilitates rapid correction of cobalamin deficiency by bypassing gastrointestinal absorption issues commonly associated with oral supplementation. It is also utilized as adjunct therapy in conditions such as megaloblastic anemia and certain neurodegenerative disorders. The typical dosage and duration of treatment should be determined by a healthcare professional based on the severity of deficiency and clinical response. Meaxon Injection is generally well tolerated; however, hypersensitivity reactions may occur in rare cases. Caution is advised in patients with known allergies to cobalamin or any component of the formulation. Proper administration techniques and adherence to prescribed dosing schedules are essential to ensure therapeutic efficacy and patient safety.